STRUCTURE, FUNCTION, AND DEVELOPMENT OF THE ACTIVE ZONE
Project Number5R01NS030051-03
Contact PI/Project LeaderKO, CHIEN-PING
Awardee OrganizationUNIVERSITY OF SOUTHERN CALIFORNIA
Description
Abstract Text
The long-term goals of this research are to elucidate the cellular and
molecular mechanisms of transmitter release and differentiation of the
presynaptic nerve terminal. The present proposal will focus on the active
zone, where transmitter release is believed to occur. It has been
postulated that Ca 2+ channels are strategically located at active zones.
This hypothesis will be tested using w-conotoxin (CTX) as a probe for Ca 2+
channels at the frog neuromuscular junction . In addition, CTX will be
used to study the correlation between active zone morphometry and synaptic
efficacy as well as the mechanisms of active zone differentiation.
(1) Thin-section electron microscopy will be used to reveal the
distribution of Ca 2+ channels in the nerve terminal and to examine if Ca
2+ channels are located preferentially at the active zone. (2)
Freeze-fracture cytochemical techniques, using CTX tagged with gold
particles, will be applied to study whether Ca 2+ channels coincide with
the large intramembrane particles seen at the active zone. (3) Quantal
contents of identified neuromuscular junctions will be measured with
intracellular recording. Active zones of the same junctions will be
stained with rhodamine-labeled CTX and visualized with a confocal
microscope. The correlation between quantal contents and active zone sizes
will be analyzed. (4) Neuromuscular junctions, during reinnervation in the
frog and during synaptogenesis in the tadpole, will be double-labeled with
rhodamine-CTX and fluorescein alpha bungarotoxin. Whether Ca 2+ channels
are initially distributed evenly throughout the nerve terminal and later
accumulated at active zones will be investigated. In addition, the
temporal and spatial relationship between clusters of Ca 2+ channels and
acetylcholine receptors during synaptogenesis will be examined.
The proposed research on two of the most important elements at the synapse,
active zones and Ca 2+ channels, will provide new insights into the
mechanisms on how the synapse works and forms. These results may lead to
further understanding on Lambert-Eaton myasthenic syndrome and may provide
morphological correlate of learning and memory which are thought to involve
changes in synaptic efficacy.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Ranaalternatives to animals in researchanimal poisoncalcium channelcell differentiationcholinergic receptorsconfocal scanning microscopydevelopmental neurobiologyelectron microscopyelectrophysiologyfluorescent dye /probehistochemistry /cytochemistrynerve endingsnervous system regenerationneurogenesisneuromuscular junctionneurotoxinsneurotransmitter transportsynapsessynaptogenesis
National Institute of Neurological Disorders and Stroke
CFDA Code
DUNS Number
072933393
UEI
G88KLJR3KYT5
Project Start Date
15-January-1992
Project End Date
31-July-1995
Budget Start Date
01-January-1994
Budget End Date
31-July-1995
Project Funding Information for 1994
Total Funding
$147,966
Direct Costs
$90,638
Indirect Costs
$57,328
Year
Funding IC
FY Total Cost by IC
1994
National Institute of Neurological Disorders and Stroke
$147,966
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01NS030051-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01NS030051-03
Patents
No Patents information available for 5R01NS030051-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01NS030051-03
Clinical Studies
No Clinical Studies information available for 5R01NS030051-03
News and More
Related News Releases
No news release information available for 5R01NS030051-03
History
No Historical information available for 5R01NS030051-03
Similar Projects
No Similar Projects information available for 5R01NS030051-03